Enhancing global laboratory systems to safely manage biological risks, deploy diagnostics, and sequence pathogens to improve capacities for global health threat response and detection
Cooperative agreement funding to strengthen global public health laboratory systems, workforce, biosafety/biosecurity, emergency preparedness, quality management, diagnostics, and pathogen sequencing capacity.
⚑ Global public health laboratory capacity-building and service-oriented implementation; not a research project. · Award ceiling listed as $0 in the notice; verify budget language in the solicitation. · Special consideration for laboratories previously funded under CDC-RFA-GH20-2109 to expand into additional countries.
Unit fits — one characterization, each unit's own rules
| IPPRA | 40 partial | portfolio topic: public_health (primary); social/behavioral work is none; funds training education, not research (capped); biomedical core — IPPRA health lane is communication/crisis/policy (capped); capped at 40 (non-research funding) |
| Physical Sciences & Engineering (demo) | 40 partial | technical depth: substantial; funds training education (capped) |
| Tom Love Innovation Hub | 30 weak | prototyping/demonstration stage; deep-tech content |
Description
Activities under this NOFO will focus on protecting and improving public health globally by: 1) strengthening public health laboratory systems; 2) improving public health laboratory workforce; 3) improving bio risk management; 4) reinforcing emergency laboratory preparedness in alignment with 7-1-7 outbreak response paradigm; 5) enhancing laboratory quality management systems and; 6) enhancing diagnostic capacity via rapid tests for low resource settings and genomic sequencing for pathogens of pandemic potential. Additionally, laboratory recipients previously funded under CDC-RFA-GH20-2109 may apply to expand efforts in additional countries with special consideration given to those countries.
Eligibility
N/A
Apply
View on Grants.gov → CONTACT: Centers for Disease Control-GHC <DGHPNOFOs@cdc.gov>
Proposal brief SEE AN EXAMPLE →
A one-page internal memo: fit assessment, submission requirements, document scaffold, and next steps dated back from the deadline — tailored to your project idea if you add one.
Proposal shell · HHS services agencies (SAMHSA / HRSA / CDC / ACF) conventions SEE AN HHS EXAMPLE →
Funder-faithful document skeletons — HHS services agencies (SAMHSA / HRSA / CDC / ACF)'s document set with section headings, page limits, reviewer guidance, and writing prompts; add a project idea to get [DRAFT] starter bullets. Download as .md for Word or Overleaf.
Legacy IPPRA LLM assessment (v2.0, for comparison)
18/100 · gpt-5.4-mini · 2026-07-06
This is primarily a global public health laboratory capacity-building and implementation/cooperative agreement opportunity, centered on diagnostics, sequencing, workforce, and biosafety rather than research. IPPRA’s fit is limited to the public health/crisis response portfolio area through potential evaluation or communication-adjacent elements, but the NOFO does not foreground a social-behavioral or policy research component, and it appears targeted to existing CDC-funded laboratory recipients.
Legacy scoring history
| 2026-07-06 | 18 | gpt-5.4-mini | This is primarily a global public health laboratory capacity-building and implementation/cooperative agreement opportunity, centered on diagnostics, sequencing, workforce, and biosafety rather than research. IPPRA’s fit is limited to the public health/crisis response portfolio area through potential evaluation or communication-adjacent elements, but the NOFO does not foreground a social-behavioral or policy research component, and it appears targeted to existing CDC-funded laboratory recipients. |
| 2026-07-06 | 18 | gpt-5.4-mini | This is a public health laboratory capacity and pathogen surveillance cooperative agreement, but it is primarily technical and implementation-focused rather than centered on the behavioral, communication, or policy research strengths that IPPRA typically leads. IPPRA could be relevant only at the margins through workforce, preparedness, or crisis-response research, and the notice appears to target existing laboratory recipients, so there is no clear opportunity for a public university to compete directly. |